STXS News and Press, Stereotaxis Inc. From 08/16/23

ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its technology will be the focus of multiple live long-distance telerobotic procedures at the upcoming...

2023-08-10 16:29:02 ET Stereotaxis, Inc. (STXS) Q2 2023 Earnings Conference Call August 10, 2023 10:00 AM ET Company Participants David Fischel - Chairman & Chief Executive Officer Kimberly Peery - Chief Financial Officer Conference Call Participants ...

2023-08-10 09:04:53 ET Stereotaxis press release ( NYSE: STXS ): Q2 GAAP EPS of -$0.07 beats by $0.01 . Revenue of $7.86M (+27.8% Y/Y) beats by $1.18M . Outlook: Stereotaxis reiterates its expectation of double-digit revenue growth in 2023 driven by revenue...

ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second quarter ended June 30, 2023. “Stereotaxis delivered 28% revenu...

2023-08-09 14:08:30 ET Stereotaxis ( NYSE: STXS ) is scheduled to announce Q2 earnings results on Thursday, August 10th, before market open. The consensus EPS Estimate is -$0.07 (flat Y/Y) and the consensus Revenue Estimate is $6.68M (+8.6% Y/Y).Over the last 1 year, STXS ...

ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients have been successfully treated utilizing Abbott’s EnSite ™ X EP System...

ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 second quarter on Thursday, August 10, 2023 before the ...

2023-06-16 14:00:02 ET Gainers: Evelo Biosciences ( EVLO ) +120% . Sientra ( SIEN ) +29% . TMC the metals company ( TMC ) +24% . ICZOOM Group ( IZM ) +20% . iRobot Corporation ( IRBT ) +20% . Marker Therapeutics ( MRKR ) ...

2023-06-16 10:08:10 ET Gainers: Oncorus ( ONCR ) +264% . Microbot Medical ( MBOT ) +24% . NeuBase Therapeutics ( NBSE ) +19% . Community Health Systems ( CYH ) +8% . Homology Medicines ( FIXX ) +4% . Losers: Panbela Therap...

ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it intends to initiate a first-in-human trial to support the CE Mark submission for its MAGiC™ cath...